Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.26 USD | +0.71% | +3.65% | +17.03% |
05:18pm | MannKind Gets FDA Approval to Begin Phase 3 Trial of Lung Disease Treatment | MT |
12:36pm | MannKind Gets FDA Clearance for Clofazimine IND Application | DJ |
Evolution of the average Target Price on MannKind Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering MannKind Corporation
Oppenheimer | |
Wedbush | |
HC Wainwright | |
SVB Securities LLC | |
RBC Capital Markets | |
SVB Leerink |
EPS Revisions
- Stock Market
- Equities
- MNKD Stock
- Consensus MannKind Corporation